Actively Recruiting
Effect of Mediterranean Diet in Inflammatory Bowel Disease
Led by University of California, San Diego · Updated on 2024-04-02
90
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel disease severity. The investigators will collect blood and stool samples from patients with inflammatory bowel disease (IBD) before and after diet changes. The stool samples will be analyzed using metabolomics and microbiome analysis to determine changes after the new diet has been implemented. The investigators will then compare changes in the patient's overall disease state by measuring markers of inflammation including C-reactive protein (CRP) and fecal calprotectin to determine how this diet affects the disease state.
CONDITIONS
Official Title
Effect of Mediterranean Diet in Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Meet classification criteria for inflammatory bowel disease including mild to moderate Crohn's Disease
- Crohn's disease activity index between 150-450
- Fecal calprotectin >250 within 1 month of enrollment
You will not qualify if you...
- Unable to provide informed consent
- History of or current drug abuse
- Pregnancy
- Start or change in dose of standard-of-care treatment within 12 weeks of screening
- Known allergy to any component of the Mediterranean diet
- Significant other medical or psychiatric conditions that may affect study results
- Not on a stable medication dose between sample collections
- Use of antibiotics
- C difficile infection within 4 weeks of enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Diego
San Diego, California, United States, 92161
Actively Recruiting
Research Team
M
Monica Guma, M.D., PhD
CONTACT
M
Mehrnaz Aghili, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here